Josh Ransom

Josh is a Head of Clinical Products at SHYFT Analytics where he is co-leading development of new software-as-a-solution (SaaS) platforms for top pharmaceutical & biotech companies. In addition, he has served leading pharmaceutical, biotechnology, and medical device companies focusing on the application of Real World Evidence to both clinical and commercial challenges as well as launch and market access for personalized medicines and other emerging medical technologies. Prior to joining SHYFT, Josh was an Associate Director in Quintiles Consulting's Emerging Technology Strategy practice and a Precision Medicine subject matter expert. Prior to joining Quintiles, Josh was a Senior Associate with McKinsey & Company in their New Jersey office with a focus on innovation strategy and commercial strategy redesign.

Josh Ransom is the Head of Clinical Products at SHYFT, based in United States, North America. With a background in Life Science, Josh Ransom has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.